BioAtla
BCAB
BCAB
80 hedge funds and large institutions have $87.6M invested in BioAtla in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
69% less capital invested
Capital invested by funds: $279M → $87.6M (-$191M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
80
Holding in Top 10
–
Calls
$147K
Puts
$128K
Top Buyers
| 1 | +$9.46M | |
| 2 | +$1.85M | |
| 3 | +$1.37M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.34M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.2M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$9.28M | |
| 3 | -$6.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.36M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$4.51M |